Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Children With Severe Asthma
The approval of benralizumab (Fasenra) is supported by evidence from the phase 3 TATE study.
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval of benralizumab (Fasenra) is supported by evidence from the phase 3 TATE study.
Positive results observed in Duchenne muscular dystrophy patients undergoing gene therapy mark a breakthrough in Illinois medical treatment.
Beacon Biosignals made waves in the healthcare tech sector today with the announcement of FDA 510(k) clearance for a progressive machine learning software designed to change the analysis of sleep patterns.
American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024
This expansion applies to the estimated 70 million patients who need either primary or secondary prevention, regardless of statin use.